Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study (Q34631940)
scientific article published on August 30, 2011
Language:
(P31) (Q13442814)
(P50) (Q57912848)
(Q99630149)
(Q104696550)
(Q114301064)
(Q101383028)
(P304) 314-321
(P407) (Q1860)
(P433) 3
(P478) 18
(P577) Tuesday, August 30, 2011
(P921) (Q8277)
(Q181600)
(Q18555066)
(P953) https://journals.sagepub.com/doi/pdf/10.1177/1352458511421054
https://journals.sagepub.com/doi/full-xml/10.1177/1352458511421054
(P1433) (Q1952449)
(P1476) "Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study" (language: en)
"Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study" (language: en)
(P2093) Eva Havrdova
Volker Limmroth
Klaus Schmierer
Mefkure Eraksoy
Eva Meluzinova
Michal Dufek
Minhua Yang
Kate Dawson
Chris H. Polman
Tarek A. Yousry
Gilmore N. O'Neill
(P2860) (Q29616022)
(Q37021184)
(Q40473279)
(Q48299419)
(Q51976135)
(Q46580263)
(Q46276281)
(Q22252943)
(Q22241644)
(Q48488976)
(Q56681074)
(Q48375029)
(Q58119404)
(Q27724077)
other details
description scientific article published on August 30, 2011

External Links